Empaglinna Tablets 25/5 mg (Empagliflozin 2L-Proline, Linagliptin)

Adult dose

The recommended starting dose for this medication is 1 time a day: Empagliflozin 10 mg (equivalent to 15.107 mg of Empagliflozin 2L-Proline) / Linagliptin 5 mg. If additional blood sugar control is needed and the patient is tolerant to Empagliflozin 10 mg/Linagliptin 5 mg, the dosage can be increased to 25/5 mg (equivalent to 37.766 mg of Empagliflozin 2L-Proline) once daily.

This medication should not be administered to certain patients. For example, those who are allergic to this medication's active ingredients, patients with type 1 diabetes, diabetic ketoacidosis, and those on dialysis should not take this medication. Patients with impaired kidney function must ensure their kidney function is checked before administration and should monitor their kidney status regularly after administration. The experience of using this medication in patients with heart failure is limited, so it should be used with caution. Acute pancreatitis may occur while taking this medication, so if symptoms such as severe abdominal pain appear, the medication should be stopped immediately, and a doctor should be consulted. Additionally, a skin condition known as bullous pemphigoid may appear, so any formation of blisters or erosion on the skin should be reported to healthcare professionals immediately. Urinary tract infections and genital infections can occur commonly when taking this medication. Women, in particular, are at a higher risk of infections, so prompt treatment should be sought if any symptoms of infection arise. There is a risk of hypoglycemia; therefore, when taken with insulin or sulfonylureas, blood sugar levels should be monitored carefully, and dosage adjustments may be necessary. Hypotension or dehydration due to fluid loss may occur, so elderly patients or those with low blood pressure should be particularly cautious, and if symptoms of dehydration occur, the administration of this medication may be temporarily halted. It is important to regularly check blood sugar levels, kidney function, and infection symptoms while taking this medication. Pregnant or breastfeeding women are advised not to use this medication, and if pregnancy is planned or occurs, a consultation with healthcare professionals should be mandatory. This medication should not be used in children under 18 years of age, as its safety and efficacy have not been established.

Serious side effects

Hives, angioedema, ketoacidosis, pancreatitis, bullous pemphigoid, severe allergic reactions, severe skin adverse reactions, shortness of breath or difficulty breathing, respiratory distress, asthma attacks, yellowing of the skin or eyes (jaundice), liver abnormality symptoms, sudden and very severe headaches, seizures, altered consciousness, visual disturbances, paralysis, significantly decreased urine output, severe generalized edema accompanied by elevated blood pressure.

Mild side effects

• Urinary tract infection
• vulvovaginal candidiasis
• vulvitis
• balanitis
• and other genital infections
• hypoglycemia
• thirst
• cough
• constipation
• oral ulcer formation

This medication is sensitive to air and moisture, so it should be stored in a tightly sealed container. The recommended storage temperature is between 1 and 30 degrees Celsius in a cool place. Storing it this way will help maintain the medication's effectiveness safely.

Appearance

Light pink triangular film-coated tablet

Package unit

30 tablets/bottle